| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Badawi David | Chief Technology Officer, Director | C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK | /s/Jeremy Hayden, Attorney-in-Fact for David Badawi | 03 Oct 2025 | 0001870825 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGHT | Common Stock | Sale | $19,728 | -6,033 | -0.32% | $3.27 | 1,864,992 | 03 Oct 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. |